Navellier & Associates’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-24,311
| Closed | -$5.95M | – | 309 |
|
|
2021
Q2 | $5.95M | Buy |
24,311
+16
| +0.1% | +$3.92K | 0.9% | 36 |
|
|
2021
Q1 | $6.43M | Buy |
+24,295
| New | +$6.43M | 1.16% | 24 |
|
|
2019
Q2 | – | Sell |
-19,784
| Closed | -$2.44M | – | 272 |
|
|
2019
Q1 | $2.44M | Buy |
19,784
+2,226
| +13% | +$274K | 0.38% | 71 |
|
|
2018
Q4 | $2.06M | Buy |
17,558
+10,499
| +149% | +$1.23M | 0.35% | 72 |
|
|
2018
Q3 | $882K | Buy |
+7,059
| New | +$882K | 0.11% | 157 |
|